About Conference
3rd Annual Meeting on Pharmaceutical Science and Drug Manufacturing & Development
May 25–26, 2026 | Paris, France
Theme: “Innovating for Safer, Faster, and Smarter Drug Development”
The 3rd Annual Meeting on Pharmaceutical Science and Drug Manufacturing & Development is a premier international event bringing together researchers, pharmaceutical professionals, industry experts, and regulatory specialists to explore the cutting-edge innovations shaping the future of drug development. The conference aims to provide an interactive platform for sharing research, exchanging ideas, and building collaborations that drive safer, more efficient, and technologically advanced pharmaceutical solutions.
Held in Paris, France, the meeting offers an inspiring environment for professionals to engage in critical discussions on emerging trends in formulation science, bioprocess engineering, quality control, and next-generation manufacturing techniques. Participants will benefit from keynote addresses, technical sessions, poster presentations, panel discussions, and networking opportunities designed to broaden perspectives and accelerate global progress.
Why Attend?
-
Gain Insights from top scientists, academicians, and industry leaders.
-
Discover Innovations in formulation, drug delivery systems, bioprocessing, and manufacturing technologies.
-
Engage & Connect with international peers, collaborators, and potential partners.
-
Present Your Research through oral or poster presentations.
Stay Updated on the latest regulatory guidelines, quality standards, and technological advancements.
Scientific Sessions / Tracks
-
Pharmaceutical Formulation & Preformulation Studies
-
Novel Drug Delivery Systems
-
Pharmaceutical Biotechnology
-
Bioprocess Engineering & Biomanufacturing
-
Drug Design, Discovery & Development
-
Quality-by-Design (QbD) & Risk Management
-
Analytical & Bioanalytical Techniques
-
GMP, GLP & Regulatory Affairs
-
Process Development & Optimization
-
Nanomedicine & Nanotechnology in Drug Manufacturing
-
Advanced Therapies & Biologics Production
-
Continuous Manufacturing & Automation
-
Pharmacovigilance & Drug Safety
-
Artificial Intelligence in Drug Development
-
Packaging, Storage & Supply Chain Management
Target Audience
-
Pharmaceutical Scientists & Researchers
-
Drug Development Specialists
-
Biotech & Biomanufacturing Professionals
-
Academia: Professors, Scholars, Students
-
Regulatory Experts & Quality Assurance Teams
-
Clinical Researchers
-
Industry Executives & Decision Makers
-
Healthcare Professionals
-
Pharmacists & Formulation Experts
Call for Abstracts
Researchers and professionals are invited to submit abstracts for oral and poster presentations.
Topics may include but are not limited to the conference tracks listed above.
Early submissions are encouraged due to limited presentation slots.
Registration Information
Participants can choose from:
-
Oral Presentation
-
Poster Presentation
-
Delegate/Listener
-
Student Participation
-
Virtual Participation
Early-bird discounts are available. Contact the organizing team for group registration options.
Venue: Paris, France
Paris is an international hub for science, innovation, and culture. With world-class conference facilities, excellent connectivity, and a vibrant scientific community, it provides the perfect setting for impactful discussions and new collaborations. Delegates will also enjoy the city’s historic attractions, cuisine, and dynamic atmosphere.
Contact Us
For inquiries, abstract submissions, or registration assistance, please contact:
Email: [contact@europeanmeets.com]
Whatsaap/Phone [+44 1520330005]
More details will be updated soon.
Tracks & Session
Tracks 1. Pharmaceutical Sciences & Drug Design
This track focuses on the discovery and optimization of new therapeutic molecules. Sessions cover medicinal chemistry, target identification, AI-assisted drug design, and pharmacokinetics/pharmacodynamics (PK/PD), and safety assessment approaches. Attendees will explore how computational tools and screening technologies accelerate early-stage drug development.
Tracks 2. Formulation & Preformulation Studies
Dedicated to transforming active pharmaceutical ingredients (APIs) into stable, effective dosage forms. Topics include excipient selection, solubility enhancement, compatibility testing, stability studies, and advanced formulation strategies for solid, liquid, and semi-solid products.
Tracks 3. Novel Drug Delivery Systems
This track highlights innovations that improve the precision, targeting, and release profiles of drug therapies. Discussions include nanoparticles, liposomes, transdermal patches, smart delivery systems, implantable devices, ocular/pulmonary delivery, and controlled-release technologies.
Tracks 4. Pharmaceutical Biotechnology
Focusing on biopharmaceutical products such as monoclonal antibodies, vaccines, therapeutic proteins, biosimilars, and gene/cell therapies. Participants will gain insights into upstream development, expression systems, purification techniques, and bioengineering advancements.
Tracks 5. Bioprocess Engineering & Biomanufacturing
A deep dive into upstream and downstream bioprocessing, including cell culture optimization, fermentation, purification technologies, process intensification, scale-up, and industry approaches for high-yield, cost-effective manufacturing of biological products.
Tracks 6. Advanced Manufacturing Technologies
Explores cutting-edge innovations such as continuous manufacturing, Process Analytical Technology (PAT), automation, robotics, digitalized facilities, and 3D-printed pharmaceuticals. Designed for those aiming to modernize production lines and achieve regulatory-compliant, next-generation workflows.
Tracks 7. Quality Control & Quality Assurance
Focused on ensuring product integrity throughout development and manufacturing. Topics include analytical method development, QbD principles, validation standards, Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), quality risk management, and regulatory compliance strategies.
Tracks 8. Regulatory Affairs & Drug Approval Process
This track addresses global regulatory frameworks (FDA, EMA, WHO), dossier preparation, CTD/eCTD submission, clinical trial regulations, pharmacovigilance obligations, and post-marketing surveillance. Ideal for professionals involved in drug registration and compliance documentation.
Tracks 9. Nanotechnology in Pharmaceuticals
Explores how nanoscale materials transform drug delivery and therapeutics. Sessions cover nanoformulations, nanocarriers for gene and drug delivery, nanosafety, characterization methods, and emerging applications of nanotechnology in manufacturing and diagnostics.
Tracks 10. Advanced Therapies & Personalized Medicine
Examines next-generation therapeutic approaches including mRNA-based drugs, CRISPR and genome editing, CAR-T and immunotherapy, regenerative medicine, and precision medicine guided by biomarkers and genetic profiling.
Tracks 11. Packaging, Storage & Pharmaceutical Logistics
Focused on protecting product quality from production to patient. Topics include packaging innovations, stability and shelf-life optimization, cold chain systems, serialization, anti-counterfeit technology, and efficient global supply chain management.
Tracks 12. AI, Data Science & Digital Health in Pharma
Highlights the growing role of digital technologies in drug development and manufacturing. Includes machine learning applications, digital twins, big data analytics, cloud-based monitoring systems, and real-time predictive modeling for process optimization.
Tracks 13. Clinical Research & Translational Medicine
Bridges laboratory discoveries to patient-ready therapies. Sessions cover clinical trial design, recruitment strategies, ethical considerations, biomarker-driven research, adaptive trials, and challenges in translating preclinical findings into human studies.
Tracks 14. Case Studies, Industry Insights & Future Trends
Provides real-world examples of successful drug development programs, regulatory challenges, commercialization strategies, sustainability in manufacturing, global market trends, and the future role of automation and AI in pharmaceutical production.
Market Analysis
The global pharmaceutical market was valued at over USD 1.5 trillion in 2024 and is projected to reach USD 2.1 trillion by 2030, growing at a CAGR of approximately 5.5%. The drug manufacturing sector alone accounts for more than USD 500 billion, driven by rising chronic disease prevalence, expanding biologics production, and the increased adoption of advanced manufacturing technologies. The biopharmaceuticals segment, valued at USD 420 billion, is expected to grow at a CAGR of 8–9%, fueled by the rapid development of vaccines, monoclonal antibodies, and cell–gene therapies. Meanwhile, the pharmaceutical contract manufacturing market is projected to surpass USD 200 billion by 2027, reflecting the growing shift toward outsourcing and scalable production models. With continuous advancements in automation, AI-driven manufacturing, and quality-by-design approaches, the global pharmaceutical manufacturing industry is entering a phase of accelerated innovation, creating significant opportunities for researchers, industry leaders, and technology providers worldwide.